05/25/2007 - National Legal News

A new study conducted at the University of Iowa shows that Celebrex aids in killing cancer cells.

Celebrex belongs to a class of drugs known as NSAIDs, or non-steroidal anti-inflammatory drugs. Other drugs in this class include Vioxx and Bextra. All three medications have been controversial due to the fact that they carry a risk of heart attack and stroke.

However, when Celebrex was tested along with other NSAIDs, researchers found that it was the only NSAID to kill 60 percent of the cancer cells in its culture. Early reports state that adding Celebrex to treatment protocols might be beneficial, despite both the short and long term risks associated with using the drug.

The study is published in the journals Molecular Carcinogenesis and Cancer Research.